Literature DB >> 20737643

Effect of patient and patient-oncologist relationship characteristics on communication about health-related quality of life.

Keri L Rodriguez1, Nichole K Bayliss, Stewart C Alexander, Amy S Jeffreys, Maren K Olsen, Kathryn I Pollak, Sarah K Garrigues, James A Tulsky, Robert M Arnold.   

Abstract

OBJECTIVE: To test the effects of patient and patient-oncologist relationship factors on the time spent communicating about health-related quality of life (HRQOL) during outpatient clinic encounters between oncologists and their patients with advanced cancer.
METHODS: Using mixed methods, we coded for duration of HRQOL talk in a subset of audio-recorded conversations from the Study of Communication in Oncologist-Patient Encounters (SCOPE) Trial. Multivariable linear regression modeling was used to investigate the relationship between duration of HRQOL talk and gender concordance, race concordance, patient education status, patient marital status, and length of the patient-oncologist relationship (i.e. number of previous visits).
RESULTS: Sixty-six encounters were analyzed that involved 63 patients and 34 oncologists. Patients were more likely to be female (51%), white (86%), married (78%), and possess a college or more advanced degree (33%). Most oncologists were male (82%) and white (82%). Mean ages were 58.8 years for patients and 44.9 years for oncologists. Regression results showed that the number of a patient's previous visits with their oncologist was significantly associated with a longer duration of HRQOL talk during their audio-recorded clinic visit. The remaining independent variables, gender concordance, race concordance, patient education status, and patient marital status were not significant predictors of duration of HRQOL talk.
CONCLUSIONS: Our findings suggest that length of the patient-oncologist relationship is related to duration of HRQOL talk. Improvements in HRQOL communication may best be achieved through efforts directed at those in earlier stages of the doctor-patient relationship.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20737643      PMCID: PMC3605884          DOI: 10.1002/pon.1829

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  37 in total

1.  Quality-of-Life assessment for routine oncology clinical practice.

Authors:  Michele Y Halyard; Carol Estwing Ferrans
Journal:  J Support Oncol       Date:  2008 May-Jun

2.  The use of quality of life data in clinical practice.

Authors:  J Morris; D Perez; B McNoe
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

3.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.

Authors:  Symone B Detmar; Martin J Muller; Jan H Schornagel; Lidwina D V Wever; Neil K Aaronson
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Preferences for involvement in medical decision-making: situational and demographic influences.

Authors:  S C Thompson; J S Pitts; L Schwankovsky
Journal:  Patient Educ Couns       Date:  1993-12-31

5.  Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.

Authors:  Laura A Siminoff; Gregory C Graham; Nahida H Gordon
Journal:  Patient Educ Couns       Date:  2006-07-24

6.  Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study.

Authors:  S H Kaplan; B Gandek; S Greenfield; W Rogers; J E Ware
Journal:  Med Care       Date:  1995-12       Impact factor: 2.983

7.  Quality of life assessment in daily clinical oncology practice: a feasibility study.

Authors:  S B Detmar; N K Aaronson
Journal:  Eur J Cancer       Date:  1998-07       Impact factor: 9.162

8.  Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences.

Authors:  Yuhua Bao; Sarah A Fox; José J Escarce
Journal:  Health Serv Res       Date:  2007-06       Impact factor: 3.402

9.  Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis.

Authors:  Tracy M Robinson; Stewart C Alexander; Margie Hays; Amy S Jeffreys; Maren K Olsen; Keri L Rodriguez; Kathryn I Pollak; Amy P Abernethy; Robert Arnold; James A Tulsky
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

10.  From research to practice: quality of life assessment in medical oncology.

Authors:  Betty Ferrell
Journal:  J Support Oncol       Date:  2008 May-Jun
View more
  5 in total

1.  Advancing the field of communication research in pediatric oncology: A systematic review of the literature analyzing medical dialogue.

Authors:  Erica C Kaye; Ashley Kiefer; Kristina Zalud; Melanie Gattas; Ian Snyder; Holly Spraker-Perlman; Justin N Baker
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

Review 2.  A systematic review of barriers to optimal outpatient specialist services for individuals with prevalent chronic diseases: what are the unique and common barriers experienced by patients in high income countries?

Authors:  Elizabeth A Fradgley; Christine L Paul; Jamie Bryant
Journal:  Int J Equity Health       Date:  2015-06-09

3.  Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.

Authors:  Gennaro A Paolella; Andrew D Boyd; Scott M Wirth; Sandra Cuellar; Neeta K Venepalli; Stephanie Y Crawford
Journal:  Pharmacy (Basel)       Date:  2018-03-08

4.  Longitudinal investigation of prognostic communication: Feasibility and acceptability of studying serial disease reevaluation conversations in children with high-risk cancer.

Authors:  Erica C Kaye; Melanie Gattas; Myra Bluebond-Langner; Justin N Baker
Journal:  Cancer       Date:  2019-09-18       Impact factor: 6.860

5.  Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer.

Authors:  R T Lugtenberg; M J Fischer; F de Jongh; K Kobayashi; K Inoue; A Matsuda; K Kubota; N Weijl; K Yamaoka; S R S Ramai; J W R Nortier; H Putter; H Gelderblom; A A Kaptein; J R Kroep
Journal:  Qual Life Res       Date:  2020-06-11       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.